Replies to post #1714 on Fusion Pharm, Inc. (FSPM)

[TraderGash]

Third quarter revenues for 2013 were less than third quarter revenues for 2012 (check their financial reports filed at otcmarkets.com). Maybe they will do better in the fourth quarter.
So far, they have only announced new sales to a company on which Dittman is a director. Not very positive.